| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.01M | 25.39M | 21.88M | 18.36M | 11.77M |
| Gross Profit | 6.40M | 19.04M | 21.20M | 16.62M | 11.22M |
| EBITDA | 738.00K | 28.47M | 0.00 | -1.72M | 0.00 |
| Net Income | 2.00M | 11.61M | 19.59M | 20.39M | 13.95M |
Balance Sheet | |||||
| Total Assets | 268.60M | 238.31M | 221.52M | 183.73M | 105.91M |
| Cash, Cash Equivalents and Short-Term Investments | 19.77M | 36.26M | 41.73M | 26.54M | 15.96M |
| Total Debt | 88.33M | 70.88M | 55.07M | 48.85M | 18.13M |
| Total Liabilities | 91.05M | 73.03M | 57.26M | 50.79M | 20.13M |
| Stockholders Equity | 177.55M | 165.28M | 164.26M | 132.94M | 85.79M |
Cash Flow | |||||
| Free Cash Flow | 21.52M | 16.92M | 10.72M | 71.92M | 9.40M |
| Operating Cash Flow | 21.52M | 16.92M | 10.72M | 9.34M | 7.53M |
| Investing Cash Flow | -22.87M | -26.38M | -25.17M | -61.83M | -8.42M |
| Financing Cash Flow | 18.33M | -2.75M | 17.71M | 56.49M | -1.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £182.02M | 5.84 | 12.06% | 8.15% | 1.29% | 11.17% | |
72 Outperform | £95.58M | 7.57 | 30.24% | 8.61% | -11.43% | -17.65% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £116.89M | 21.20 | 1.79% | 3.29% | -9.37% | ― | |
64 Neutral | £142.13M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
63 Neutral | £129.32M | 7.54 | 2.71% | 9.74% | 2.13% | -61.22% | |
62 Neutral | £142.43M | 11.98 | 17.51% | 17.93% | -16.53% | -44.15% |